Ligand validation:3IFC

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 3IFC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3IFC_AMP_A_339	87%	25%	0.075	0.948	1.27	1.79	3	7	1	0	100%	1
3IFC_AMP_C_339	86%	36%	0.077	0.946	0.97	1.55	1	4	0	0	100%	1
3IFC_AMP_B_339	77%	34%	0.094	0.934	1.29	1.33	2	2	2	0	100%	1
3IFC_AMP_D_339	76%	30%	0.093	0.928	1.34	1.47	3	4	2	0	100%	1
5ET6_AMP_A_401	94%	31%	0.072	0.971	1.08	1.64	2	5	0	0	100%	1
3IFA_AMP_A_339	90%	30%	0.084	0.968	1.18	1.62	3	5	0	0	100%	1
4HE2_AMP_A_401	51%	43%	0.193	0.947	0.99	1.22	2	2	0	0	100%	1
8YNQ_AMP_D_504	100%	43%	0.041	0.99	0.96	1.26	1	2	11	0	100%	1
3G89_AMP_B_304	100%	32%	0.038	0.986	1.05	1.63	1	4	6	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.78
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.